Strauss Troy Presents Commercial Real Estate Seminar on June 7

Strauss Troy will present an in-house seminar, “Advanced Topics in Commercial Real Estate” on Wednesday, June 7, beginning at 9 a.m.  The presentation qualifies for 6.0 CLE Credit Hours; 6.0 Business, Commercial and Industrial Real Property Law. The presentation will be via a DVD provided by the Ohio State Bar Association.   To register, please contact …Read More

Strauss Troy’s Award-Winning Attorneys

Our nationally recognized attorneys work together as a team to be your legal partner, whether you need an attorney to handle a personal or a corporate matter. Strauss Troy has been recognized by U.S. News – Best Lawyers as a Best Law Firm in the following practice areas: Commercial Litigation Mass Tort/Class Actions – Plaintiffs Real Estate …Read More

Strauss Troy Investigates DePuy Hip Replacements

Strauss Troy is currently evaluating cases involving Johnson and Johnson’s DePuy hip replacements. While Johnson and Johnson promoted the DePuy “metal-on-metal” hip replacements as lasting longer than similar devices that included ceramic or plastic materials, the truth was exactly the opposite. In fact, the five-year failure rate on some of the DePuy hips is close …Read More

Strauss Troy Investigates Companies Purchasing Annuities for Violation of Interest Rate Statutes

Strauss Troy is investigating companies that purchase structured settlement annuities and retirement annuities. These purchases result an individual receiving a lump sum of money in exchange for giving up a stream of payments from an annuity. Individuals typically come to receive payments from an annuity either because they have entered into a structured settlement as …Read More

Strauss Troy Files Lawsuit Alleging Bayer’s Prescription Drug Xarelto® Causes Internal Bleeding

Strauss Troy Files Lawsuit Alleging GlaxoSmithKline’s Prescription Drug Zofran® Causes Birth Defects

Strauss Troy Co. has filed a civil lawsuit in federal court in the Southern District of Ohio against Bayer, manufacturer of the drug Xarelto®, and Janssen Pharmacefuticals (a subsidiary of Johnson & Johnson that marketed the drug in the U.S.). Xarelto (generic name rivaroxaban) is generally referred to as a blood thinner. It is prescribed …Read More

Defamation Statute of Limitations: Act Quickly, Before It’s Too Late

In today’s media-saturated world, where the power of the internet can bring global attention in an instant, the threat of unfair criticism is ever present. But when criticism is based on a false statement, that can cross the line into unlawful defamation. The law can protect you if you are the victim of defamation, but …Read More